BlackRock’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-39,706
Closed -$52.4K 5452
2024
Q3
$52.4K Buy
39,706
+428
+1% +$565 ﹤0.01% 4757
2024
Q2
$299K Hold
39,278
﹤0.01% 4413
2024
Q1
$354K Sell
39,278
-6
-0% -$54 ﹤0.01% 4406
2023
Q4
$421K Hold
39,284
﹤0.01% 4389
2023
Q3
$236K Sell
39,284
-11
-0% -$66 ﹤0.01% 4566
2023
Q2
$271K Sell
39,295
-6,273
-14% -$43.3K ﹤0.01% 4572
2023
Q1
$715K Sell
45,568
-5,035
-10% -$79.1K ﹤0.01% 4358
2022
Q4
$1.01M Buy
50,603
+901
+2% +$18K ﹤0.01% 4327
2022
Q3
$887K Sell
49,702
-575
-1% -$10.3K ﹤0.01% 4433
2022
Q2
$1.12M Sell
50,277
-105,544
-68% -$2.34M ﹤0.01% 4405
2022
Q1
$4.33M Sell
155,821
-4,056
-3% -$113K ﹤0.01% 3965
2021
Q4
$7.26M Sell
159,877
-83
-0.1% -$3.77K ﹤0.01% 3777
2021
Q3
$13.3M Sell
159,960
-26
-0% -$2.17K ﹤0.01% 3483
2021
Q2
$15.2M Buy
159,986
+106,203
+197% +$10.1M ﹤0.01% 3397
2021
Q1
$8.95M Buy
53,783
+36,632
+214% +$6.1M ﹤0.01% 3583
2020
Q4
$1.68M Buy
17,151
+13,915
+430% +$1.36M ﹤0.01% 4012
2020
Q3
$110K Sell
3,236
-34
-1% -$1.16K ﹤0.01% 4393
2020
Q2
$185K Buy
3,270
+1,509
+86% +$85.4K ﹤0.01% 4296
2020
Q1
$103K Hold
1,761
﹤0.01% 4273
2019
Q4
$139K Sell
1,761
-145
-8% -$11.4K ﹤0.01% 4322
2019
Q3
$191K Buy
1,906
+260
+16% +$26.1K ﹤0.01% 4280
2019
Q2
$219K Sell
1,646
-1,608
-49% -$214K ﹤0.01% 4293
2019
Q1
$547K Sell
3,254
-64
-2% -$10.8K ﹤0.01% 4029
2018
Q4
$364K Sell
3,318
-115
-3% -$12.6K ﹤0.01% 4084
2018
Q3
$755K Buy
3,433
+646
+23% +$142K ﹤0.01% 3964
2018
Q2
$5.97M Buy
2,787
+1,572
+129% +$3.37M ﹤0.01% 3416
2018
Q1
$3.02M Sell
1,215
-14
-1% -$34.8K ﹤0.01% 3530
2017
Q4
$2.19M Buy
1,229
+10
+0.8% +$17.8K ﹤0.01% 3617
2017
Q3
$1.44M Buy
1,219
+22
+2% +$26K ﹤0.01% 3728
2017
Q2
$885K Buy
1,197
+79
+7% +$58.4K ﹤0.01% 3825
2017
Q1
$767K Buy
+1,118
New +$767K ﹤0.01% 3816
2013
Q3
Sell
-1
Closed -$5K 3097
2013
Q2
$5K Buy
+1
New +$5K ﹤0.01% 3025